Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
180
datasets available to search
ShareScore release 0.9.0
Dataset results
180 results for “FOLFIRI”
Study to Determine Safety, Pharmacokinetics, Pharmacodynamics of BAY73-4506 in Combination With mFOLFOX6 or FOLFIRI
ClinicalTrials.gov study NCT00934882. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Trial in Metastatic Colorectal Cancer With FOLFIRI Plus Aflibercept as First Line Treatment
ClinicalTrials.gov study NCT02624726. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Panitumumab Plus FOLFIRI in First-line Treatment of Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT00508404. IPD Sharing: Not stated. Countries: 0. Publications: 4.
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
ClinicalTrials.gov study NCT06252649. IPD Sharing: YES. Countries: 33. Publications: 0.
Cetuximab and Vemurafenib Plus FOLFIRI for BRAF V600E Mutated Advanced Colorectal Cancer (IMPROVEMENT)
ClinicalTrials.gov study NCT03727763. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Un
ClinicalTrials.gov study NCT02820857. IPD Sharing: NO. Countries: 1. Publications: 1.
CMAB009 Combined With FOLFIRI First-line Treatment in Patients With RAS/BRAF Wild-type, Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT03206151. IPD Sharing: NO. Countries: 1. Publications: 1.
Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC
ClinicalTrials.gov study NCT00469443. IPD Sharing: Not stated. Countries: 1. Publications: 1.
FOLFOXIRI Compared With FOLFIRI for Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT01219920. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Sunitinib in Patients With Advanced Gastric Cancer and Treated With FOLFIRI
ClinicalTrials.gov study NCT01020630. IPD Sharing: Not stated. Countries: 1. Publications: 1.
5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC)
ClinicalTrials.gov study NCT00433927. IPD Sharing: Not stated. Countries: 1. Publications: 12.
Influence of BRAF and PIK3K Status on the Efficacy of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFIRI) Plus Bevacizumab or Cetuximab in Patients With RAS Wild-type Metastatic Colorectal Carcinoma and <
ClinicalTrials.gov study NCT01640444. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Ca
ClinicalTrials.gov study NCT06106308. IPD Sharing: NO. Countries: 1. Publications: 1.
Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors
ClinicalTrials.gov study NCT01858662. IPD Sharing: Not stated. Countries: 1. Publications: 54.
Regorafenib Plus FOLFIRI With Irinotecan Dose Escalated in Patients With Previously Treated Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT03880877. IPD Sharing: NO. Countries: 1. Publications: 2.
Trial of FOLF(HA)Iri Versus FOLFIRI in mCRC
ClinicalTrials.gov study NCT01290783. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy
ClinicalTrials.gov study NCT00967616. IPD Sharing: YES. Countries: 5. Publications: 0.
Study of FOLFIRI Plus Cetuximab Plus IMO-2055 in Patients With Colorectal Cancer
ClinicalTrials.gov study NCT00719199. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Trial of Intraperitoneal (IP) Oxaliplatin in Combination With Intravenous FOLFIRI
ClinicalTrials.gov study NCT02833753. IPD Sharing: NO. Countries: 1. Publications: 15.
Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma
ClinicalTrials.gov study NCT03959293. IPD Sharing: NO. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.